DLA Piper advises Mast Therapeutics in merger agreement with Savara
DLA Piper represented San Diego-based Mast Therapeutics, Inc., a biopharmaceutical company that makes clinical-stage therapies for serious or life-threatening diseases, in a merger agreement with Savara Inc., a specialty pharmaceutical company focusing on developing treatments for rare respiratory diseases.